Lower urinary tract symptoms and falls risk among older women receiving home support: a prospective cohort study.
Kathleen F Hunter, Donald Voaklander, Zoe Y Hsu...
https://pubmed.ncbi.nlm.nih.gov/23672343/Actively Recruiting
Led by Northwell Health · Updated on 2026-06-15
40
Participants Needed
2
Research Sites
N/A
Total Duration
This research evaluates the PureWick Urine Collection System as a non-invasive way to manage nocturia in women aged 50 and older. Nocturia, which involves waking at night to urinate, is common in older adults and increases the risk of falls and fractures. The study aims to assess whether using PureWick can reduce nighttime bathroom trips and improve sleep quality and overall life quality. Participants use the PureWick System, which includes an external catheter, tubing, and a collection canister. The device allows urine collection while remaining in bed, potentially lowering fall risk. The study is a single-group pilot conducted at one center, with follow-up lasting up to 3 months to observe urinary and sleep outcomes, as well as any related adverse events. During the study, participants are monitored for changes in the number of nocturia episodes, sleep quality via questionnaires, and other health factors such as urinary tract infections and skin condition. Data is collected at the start and after 3 months of device use. Researchers will measure how many patients achieve a 50% or greater reduction in nighttime urination, along with quality-of-life improvements and safety outcomes.
CONDITIONS
A Pilot Study to Evaluate PureWick for Nocturia
B
Bilal Chughtai, MD
J
Jennifer Polo, CCRC
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Northwell Health
Lead Sponsor
Becton, Dickinson and Company
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | PureWick external urine collection device | Typical nocturia care (lifestyle and usual treatments) |
|---|---|---|
| what it is | A medical device that gently draws urine away via an external wicking system for nighttime void management | Current nocturia care typically involves lifestyle adjustments and usual treatments, such as managing fluid intake and treating underlying causes |
| role in trial | Used by all enrolled participants as the only intervention during the study | Not part of this study design; represents usual care outside the trial |
| primary use | Manage nocturia by collecting urine during sleep without an indwelling catheter | Reduce nighttime urination through behavioral measures, bladder monitoring and pharmacologic or other treatments as needed |
| how it is given or performed | Placed externally at night, connected to a suction system to passively collect urine | Implemented by patients through self‑management of habits and possible medications prescribed by clinicians |
| evidence status | Evidence pending; trial will measure reduction in nocturia episodes at 3 months | Supported by clinical guidelines recommending lifestyle measures as effective first‑line therapy |
| important risks | Not specified in registry; potential skin or urine‑related device risks are undefined | Lifestyle measures are generally low‑risk; pharmacologic or procedural treatments have standard known risks |
| important limitations | Single‑group pilot study with no direct comparison to standard care | Effectiveness depends on adherence; may not sufficiently reduce nocturia for all individuals |
| patient impact | Not yet established; trial will assess changes in nocturia frequency and quality‑of‑life scores | Lifestyle modifications may improve symptoms and quality of life when followed |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening visit
Duration - 3 months
Participants use the PureWick Urine Collection System to manage nighttime urination while in bed.
Visits at baseline and at 3 months for assessments
Duration - Up to 3 months after treatment starts
Researchers collect data on urinary episodes, sleep quality, and any adverse events related to the device.
Assessments at baseline and 3 months
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Kathleen F Hunter, Donald Voaklander, Zoe Y Hsu...
https://pubmed.ncbi.nlm.nih.gov/23672343/Medical Advisory Secretariat
https://pubmed.ncbi.nlm.nih.gov/23074507/Pauline E Chiarelli, Lynette A Mackenzie, Peter G Osmotherly
https://pubmed.ncbi.nlm.nih.gov/19463079/Terrie Beeson, Carmen Davis
https://pubmed.ncbi.nlm.nih.gov/29394218/Northwell Health
Lead Sponsor
Becton, Dickinson and Company
Collaborating Sponsor